Please try another search
Tractor Supply Company (NASDAQ:TSCO) has delivered lower-than-expected results in fourth-quarter 2019. Results were hurt by soft comparable store sales performance in the reported quarter, owing to...
Hologic, Inc. (NASDAQ:HOLX) reported first-quarter fiscal 2020 adjusted earnings per share (EPS) of 61 cents, up 5.2% year over year. The bottom line was in line with the Zacks Consensus Estimate.On...
Quest Diagnostics Incorporated’s (NYSE:DGX) fourth-quarter 2019 adjusted earnings per share (EPS) of $1.67 surpassed the Zacks Consensus Estimate by 4.4%. Adjusted earnings also improved 23.7%...
SEI Investments Co.’s (NASDAQ:SEIC) fourth-quarter 2019 earnings of 84 cents per share lagged the Zacks Consensus Estimate of 86 cents. However, the figure reflects a rise of 15.1% from the...
Illumina, Inc.’s (NASDAQ:ILMN) fourth-quarter fiscal 2019 adjusted earnings per share (EPS) of $1.70 surpassed the Zacks Consensus Estimate by 6.9%. Moreover, the bottom line improved 28.8%...
Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) announced that it has completed patient enrollment in the phase III REVERSE study, currently evaluating obeticholic acid (OCA) for the treatment of...
Marsh & McLennan Companies, Inc. (NYSE:MMC) delivered fourth-quarter 2019 adjusted earnings per share of $1.19, surpassing the Zacks Consensus Estimate by 0.8% on the back of solid revenues....
Schneider National’s (NYSE:SNDR) fourth-quarter 2019 earnings (excluding 6 cents from non-recurring items) of 37 cents per share missed the Zacks Consensus Estimate by 2 cents. The bottom line...
United Parcel Service’s (NYSE:UPS) fourth-quarter 2019 earnings (excluding $2.23 from non-recurring items) of $2.11 per share edged past the Zacks Consensus Estimate by a penny. The bottom...
The Coca-Cola Company (NYSE:KO) has delivered top and bottom-line beat in fourth-quarter 2019. Revenues benefited from robust volume and strong pricing. Further, the company provided the outlook for...
Eli Lilly and Company (NYSE:LLY) announced that the FDA has granted priority review to its new drug application (NDA) for selpercatinib (LOXO-292), an oral RET inhibitor. The NDA is seeking approval...
Thermo Fisher Scientific Inc.'s (NYSE:TMO) fourth-quarter 2019 adjusted earnings per share (EPS) of $3.55 beat the Zacks Consensus Estimate by a penny. The figure also improved from the year-ago...
Meritage Homes Corporation’s (NYSE:MTH) shares increased more than 7% in the after-hour trading session on Jan 29, post the company reported better-than-expected earnings in fourth-quarter...
Biogen Inc. (NASDAQ:BIIB) reported fourth-quarter 2019 earnings per share of $8.34, which comprehensively beat the Zacks Consensus Estimate of $8.00. Earnings rose 19% year over year, backed by...
CMS Energy Corporation (NYSE:CMS) reported fourth-quarter 2019 adjusted earnings per share (EPS) of 68 cents, up 70% from the year-ago quarter reported figure of 40 cents. The bottom line however...